Tejas Savant
Stock Analyst at Morgan Stanley
(0)
Main Sectors:
Top Industries:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
CTKB Cytek Biosciences | Maintains: Equal-Weight | 9 7 | 3.12 | 124.36% | 9 | May 28, 2025 | |
TXG 10x Genomics | Maintains: Overweight | 26 18 | 10.8 | 66.67% | 14 | May 19, 2025 | |
ILMN Illumina | Maintains: Equal-Weight | 136 100 | 90.66 | 10.3% | 8 | May 12, 2025 | |
TEM Tempus AI | Maintains: Overweight | 60 65 | 65.67 | -1.02% | 3 | May 9, 2025 | |
HOLX Hologic | Maintains: Equal-Weight | 77 65 | 64.43 | 0.88% | 9 | May 5, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 8 7 | 6.57 | 6.54% | 2 | May 5, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 7 9 | 10.52 | -14.45% | 12 | May 5, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 17 10 | 6.97 | 43.47% | 13 | May 1, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 25 15 | 13.45 | 11.52% | 17 | Apr 28, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 7 5 | 2.12 | 135.85% | 13 | Mar 25, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 16 20 | 43.04 | -53.53% | 2 | Mar 18, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 176 185 | 170.47 | 8.52% | 13 | Mar 5, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 245 250 | 155.41 | 60.86% | 11 | Feb 11, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 647 678 | 400.32 | 69.36% | 14 | Jan 31, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Equal-Weight | 24 23 | 23.63 | -2.67% | 1 | Dec 3, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 26 28 | 26.66 | 5.03% | 12 | Nov 18, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 32 21 | 4.87 | 331.21% | 2 | Nov 18, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 4 2 | 1.19 | 68.07% | 11 | Aug 12, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 4 3 | 1.28 | 134.38% | 10 | Aug 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 80 40 | 8.54 | 368.38% | 2 | May 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 26 26 | n/a | n/a | 12 | Mar 26, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 14 8 | n/a | n/a | 11 | Oct 24, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 52 55 | n/a | n/a | 11 | Aug 30, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Equal-Weight | 1 | n/a | n/a | 1 | Aug 18, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Equal-Weight | 6 6 | 0.7 | 757.14% | 3 | Aug 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 11 10 | 3.05 | 227.87% | 8 | May 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Equal-Weight | 3 | 3.17 | -13.25% | 6 | Mar 7, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 11 5 | 6.2 | -19.35% | 12 | Feb 27, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 11 10 | 1.98 | 405.05% | 10 | Feb 21, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 80 73 | 48.52 | 50.45% | 9 | Feb 21, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 5 2 | n/a | n/a | 5 | Jan 5, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 10 8 | n/a | n/a | 4 | Aug 11, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | 10 5 | n/a | n/a | 8 | Aug 10, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 350 250 | 147.42 | 69.58% | 1 | Aug 4, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 7 5 | n/a | n/a | 5 | May 12, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 17 19 | n/a | n/a | 3 | May 6, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 18 17 | n/a | n/a | 8 | May 4, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 21 20 | n/a | n/a | 2 | Mar 15, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 35 65 | n/a | n/a | 1 | Feb 22, 2021 |